Nirma To Raise Rs 4,000 Crore To Fund Lafarge Buy: Report
Mumbai: Domestic detergents major Nirma, which on Monday agreed to buy LafargeHolcim's stake in Lafarge India for an enterprise value of about $1.4 billion, will be hitting the market with a Rs 4,000-crore bond issue to part fund the acquisition.
"Nirma will be raising Rs 4,000 crore from the market to part fund the Lafarge cement acquisition. When completed this will be largest rupee bond issue to fund an acquisition in the country. The issue will hit the market shortly," two merchant banking sources told PTI here.
They said the Ahmedabad-based company has appointed Barclays, Credit Suisse and IDFC to manage the issue.
The company, the maker of soaps and chemicals, could not be contacted immediately for confirmation.
Earlier in the day, Swiss cement giant LafargeHolcim announced it has entered into an agreement to sell its assets in Lafarge India to Nirma for $1.4 billion, or about Rs 9,400 crore.
"We have entered into a letter of agreement with Nirma, subject to approval by the Competition Commission for the divestment of its interest in Lafarge India for an enterprise value of approximately $1.4 billion," LafargeHolcim said in a statement.
The diversified group has presence in soaps, detergents, salt, soda ash, caustic soda, cement and packaging, among others. It has 12 manufacturing facilities in the country and the US, and has a turnover of over Rs 7,300 crore.
The agreement, part of the building material major's 3.5 billion Swiss francs (about $3.6 billion) divestment plan, is key to get approval of fair trade regulator CCI for the multi-billion dollar global merger between Lafarge and Holcim that was announced last year.
Lafarge India operates three plants and two grinding stations with a total capacity of around 11 million tonnes per annum.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.